EPHA2 and neoplasm: One promising target is EphA2 (Ephrin receptor A2), which is highly expressed in PDAC and implicated in cancer progression through its roles in cell adhesion, migration, proliferation, and the maintenance of the tumor's immune suppressive microenvironment 15.